Citigroup cuts Acadia Pharmaceuticals target price to $33 from $40
ACAD•Citigroup cut its target price for Acadia Pharmaceuticals to $33 from $40.
Related News
Gold on track for weekly loss as Fed rate hike expectations build
GLD•
AngloGold Ashanti hosts investor site visit to Nevada Beatty gold district projects
AU•
Valor Energy may offer up to $500 million in securities
VAI•
CarMax Inc.: Stephens raises target price to $74 from $66
KMX•
PLDT clarifies hard-copy request process for 2025 Form 20-F financial statements
PHI•